Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Post by KayDayon Dec 22, 2010 8:30pm
466 Views
Post# 17886066

Wow

WowI almost missed this release, thank goodness for my blackberry alerts.

What more could you ask for!  Did you notice the change in the tone of the NR... these guys are serious... no "buts" this time.  I knew that they would have a good idea about the outcome after the meeting and wouldn't release the decision but... this reminds me of when you are busting to tell a secret and say everything but what you can't say.

I can't wait for the market to open tomorrow...  This NR has us primed for the partnership announcement that I believe is imminent.
Bullboard Posts